With more than 600 professionals and more than 200 years of combined scientific experience, SSI Diagnostica Group serves both as a partner, developer, and manufacturer to the vaccine industry. We apply our unique experience to solutions across disease prevention, disease monitoring, and disease diagnostics. Our innovative portfolio covers three disease areas: gastrointestinal, respiratory, and bloodborne (incl. tropical) diseases, with technologies, products and services spanning from bacterial strains, antisera and antigens to quantitative immunoassays and rapid screening.